150 related articles for article (PubMed ID: 4302959)
21. Modification of encephalomyocarditis virus-induced diabetes in mice by antiviral agents.
Powers RD; Dotson WM; Hayden FG
Antiviral Res; 1983 Sep; 3(3):151-9. PubMed ID: 6197026
[TBL] [Abstract][Full Text] [Related]
22. Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: a unique effect unrelated to interferon.
Ankel H; Mittnacht S; Jacobsen H
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2355-64. PubMed ID: 2414395
[TBL] [Abstract][Full Text] [Related]
23. [Effect of exogenous and endogenous interferon on the Aujeszky's disease virus].
Furer NM; Preobrazhenskaia EA
Antibiotiki; 1967 Dec; 12(12):1099-102. PubMed ID: 4877313
[No Abstract] [Full Text] [Related]
24. Production of an interferon-like agent following inoculation with bacterial vaccine.
Degre M; Dahl H
Proc Soc Exp Biol Med; 1971 May; 137(1):233-6. PubMed ID: 4325773
[No Abstract] [Full Text] [Related]
25. The role of interferon in tick-borne encephalitis virus-infected L cells. IV. Origin of insusceptibility of persistently infected L cells to the action of exogenous interferon.
Stancek D
Acta Virol; 1965 Sep; 9(5):409-15. PubMed ID: 4379466
[No Abstract] [Full Text] [Related]
26. Sensitivity to, and production of interferon by three variants of Mengo virus.
Campbell JB; Colter JS
Can J Microbiol; 1967 Aug; 13(8):931-7. PubMed ID: 4292852
[No Abstract] [Full Text] [Related]
27. Physical dependence to morphine diminishes the interferon response in mice.
Lorenzo P; Portolés A; Beneit JV; Ronda E; Portolés A
Immunopharmacology; 1987; 14(2):93-9. PubMed ID: 2448267
[TBL] [Abstract][Full Text] [Related]
28. Comparison of cytotoxicity and antiviral activity of 1-beta-D-arabino-furanosyl-5-iodocytosine with related compounds.
Renis HE
Cancer Res; 1970 Jan; 30(1):189-94. PubMed ID: 5466741
[No Abstract] [Full Text] [Related]
29. Inducers of interferon and host resistance, V. In vitro studies.
Field AK; Tytell AA; Lampson GP; Hilleman MR
Proc Natl Acad Sci U S A; 1968 Sep; 61(1):340-6. PubMed ID: 4301592
[No Abstract] [Full Text] [Related]
30. Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1.
Lerner AM; Bailey EJ
J Infect Dis; 1974 Nov; 130(5):549-52. PubMed ID: 4371532
[No Abstract] [Full Text] [Related]
31. Relationship between dose size and dose interval of polyinosinic polycytidylic acid and interferon hyporesponsiveness in mice.
DuBuy HG; Johnson ML; Buckler CE; Baron S
Proc Soc Exp Biol Med; 1970 Nov; 135(2):340-4. PubMed ID: 5479996
[No Abstract] [Full Text] [Related]
32. [Stimulation of interferon formation in tissue culture by means of 8-mercaptoadenine].
Braude AI; Shcherbakova EG; Smertenko II; Furer NM; Rastunova GA
Antibiotiki; 1969 Oct; 14(10):915-8. PubMed ID: 4311306
[No Abstract] [Full Text] [Related]
33. Reversible inhibition of interferon synthesis by puromycin: evidence for an interferon-specific messenger RNA.
Wagner RR; Huang AS
Proc Natl Acad Sci U S A; 1965 Oct; 54(4):1112-8. PubMed ID: 4160614
[No Abstract] [Full Text] [Related]
34. Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers.
Merigan TC; Finkelstein MS
Virology; 1968 Jul; 35(3):363-74. PubMed ID: 4298648
[No Abstract] [Full Text] [Related]
35. Antiviral and cell-growth inhibitory activities of highly purified L-cell interferon. An analysis of quantitative disproportions.
Fuchsberger N; Hajnická V; Boreckyý L
Acta Virol; 1975 Jan; 19(1):59-66. PubMed ID: 235199
[TBL] [Abstract][Full Text] [Related]
36. Nucleic acids. 3. Antiviral activity of nucleotides and dinucleoside phosphates containing ara-cytidine.
Renis HE; Hollowell CA; Underwood GE
J Med Chem; 1967 Sep; 10(5):777-82. PubMed ID: 4292736
[No Abstract] [Full Text] [Related]
37. Influence of statolon on resistance of mice to influenza.
Pindak FF; Schmidt JP; Kendrick JZ
Appl Microbiol; 1969 Aug; 18(2):147-51. PubMed ID: 4308934
[TBL] [Abstract][Full Text] [Related]
38. [Loss of cellular sensitivity to endogenous interferon induced with the murine sarcoma virus].
Canivet M; Periés J; Olivié M; Boiron M
C R Acad Hebd Seances Acad Sci D; 1972 Feb; 274(7):1106-8. PubMed ID: 4336176
[No Abstract] [Full Text] [Related]
39. Protective effect of interferon inducers on Plasmodium berghei malaria.
Jahiel RI; Nussenzweig RS; Vilcek J; Vanderberg J
Am J Trop Med Hyg; 1969 Nov; 18(6):823-35. PubMed ID: 5389768
[No Abstract] [Full Text] [Related]
40. [Effect of inhibitors that destroy cytoskeleton structures on the antiviral and antiproliferative activity of interferons].
Solov'eva MF; Krispin TI; Shloma DV; Kalmakhelidze KA; Balandin IG
Vopr Virusol; 1988; 33(3):309-14. PubMed ID: 2459850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
